Shares of QuidelOrtho Corporation (QDEL), a diagnostic testing technologies and solutions provider, are rising more than 9% Thursday morning after the company reported preliminary first-quarter revenue, above analysts’ view.
The company expects revenue in the first quarter to be in the range of $840 million to $850 million, driven by strong results in its Labs business as well as better-than-expected results in the Point of Care business.
On average 8 analysts polled by Thomson-Reuters are expecting revenue of $746.75 million for the quarter.
First-quarter results are scheduled to be reported on May 3.
Source: Read Full Article
Lates News:
-
Helen Of Troy Q1 Results Down, But Beats Estimates; Backs FY24 Outlook; Stock Up In Premarket
-
Hopes Of A Spot Bitcoin ETF Dashed As SEC Again Extends ARK Deadline To January
-
Markets Anxious As Oil Price Surge Spotlights Inflationary Fears
-
Rite Aid Corp. Slips On Wider Loss In Q3
-
Cryptos Firm As The Dollar Retreats